Researchers at Emory University will use VivaLNK’s ambulatory ECG patch to study autonomic function in patients undergoing coronary angiography.

The study will assess autonomic function in predicting coronary artery disease (CAD) and its relationship to depression, as well as long-term outcomes.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

The ECG patch features an electrocardiography sensor and accelerometer capable of capturing and generating multiple physiological data, including ECG trace, heart rate, RR-interval and 3-axis motion.

The patch weighs around 7.5g and can be reused and recharged. After 72 hours of continuous wear, data can be captured and transmitted in real-time.

Emory University Rollins School of Public Health Epidemiology assistant professor Amit Shah said: “VivaLNK’s ECG patch is very small and comfortable to wear, which are important factors for clinical use and long-term ECG monitoring.

“In addition, the software development kit makes it easy to use the patch for research and product development purposes.”

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

During the trial, researchers can remotely monitor patients undergoing coronary angiography using the ECG patch to measure autonomic function.

Patients will be continuously observed for 72 hours within a clinical and ambulatory atmosphere, providing a complete representation in a natural setting.

The research is aimed to provide a better understanding of the role of the autonomic nervous system during depression and CAD.

Furthermore, the research will pave the way for the development of better tools for clinical assessment.

In December 2017, VivaLNK unveiled its Vital Scout assessment patch with electrocardiography (ECG) and three-dimensional (3D) accelerometer sensors to monitor vital signs.

The patch leverages the company’s breathable and non-invasive eSkin technology, a thin electronic substrate used for sensor integration and data services.